Method of treating functional bowel disorders
OwnerSteven Landauinventor
Life of this patent
Estimating the term…
Abstract
The invention relates to a method of treating at least one symptom of irritable bowel syndrome selected from the group consisting of: abnormal stool frequency, abnormal stool form, abnormal stool passage, passage of mucus and feeling of abdominal distension in a subject in need thereof. In certain embodiments, the pain and discomfort associated with irritable bowel syndrome is also reduced. The method comprises administering to a subject in need of treatment a therapeutically effective amount of a compound that has 5-HT3 receptor antagonist activity and NorAdrenaline Reuptake Inhibitor (NARI) activity.
Claims20
A method of treating at least one symptom of irritable bowel syndrome selected from the group consisting of:
- abnormal stool frequency, abnormal stool form, abnormal stool passage, passage of mucus and feeling of abdominal distension in a subject in need thereof comprising administering to said subject a therapeutically effective amount of a compound of Formula I:
- wherein, R1 and R2 independently represent hydrogen, halogen or a C1-C6 alkyl group;
- or R1 and R2 together with the carbon atom to which they are attached form a cycloalkylene group having 5 to 6 carbon atoms;
- R3 and R4 independently represent hydrogen or a C1-C6 alkyl group;
- R5 is hydrogen, C1-C6 alkyl,
- or —C(O)—NH—R6
- wherein m is an integer from about 1 to about 3, X is halogen and R6 is a C1-C6 alkyl group;
- and
- Ar is a substituted or unsubstituted phenyl, 2-thienyl or 3-thienyl group;
- and
- n is 2 or 3;
- or a pharmaceutically acceptable salt thereof.
A method of treating at least one symptom of irritable bowel syndrome selected from the group consisting of:
- abnormal stool frequency, abnormal stool form, abnormal stool passage, passage of mucus and feeling of abdominal distension in a subject in need thereof comprising administering to said subject a therapeutically effective amount of a compound of Formula II:
- or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.